Relation between bioresorbable scaffold sizing using QCA-Dmax and long-term clinical outcomes in 1,232 patients from three study cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)
Yuki Katagiri(University of Amsterdam), Patrick W. Serruys(Erasmus MC), Joanna J. Wykrzykowska(University Medical Center Groningen), Yoshinobu Onuma(Ollscoil na Gaillimhe – University of Galway), Yosuke Miyazaki(Yamaguchi University), Alexandre Abizaid(Universidade de São Paulo), Carlos Collet(Onze Lieve Vrouwziekenhuis Hospital), Taku Asano(Amsterdam UMC Location University of Amsterdam), Ply Chichareon(Prince of Songkla University), Bernard Chevalier(University of Zurich), John A. Ormiston(Auckland City Hospital), Jan J. Piek(Amsterdam University Medical Centers)
Cited by 6
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
2024 ESC Guidelines for the management of chronic coronary syndromes
|European Heart Journal|2024|2.3k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k